South Rampart Pharma Receives $1.9 Million NIH Fast-Track STTR Commercialization Grant to Advance its New Class of Non-Opioid Pain Medicines
September 29, 2020 08:00 ET
|
South Rampart Pharma
NEW ORLEANS, Sept. 29, 2020 (GLOBE NEWSWIRE) -- South Rampart Pharma, a company committed to improving the lives of people suffering from pain by developing a new class of non-opioid pain medicines,...
South Rampart Pharma Identifies New Class of Non-Opioid Pain Medicines in European Journal of Medicinal Chemistry Publication
July 14, 2020 08:00 ET
|
South Rampart Pharma
NEW ORLEANS, July 14, 2020 (GLOBE NEWSWIRE) -- South Rampart Pharma, LLC ("South Rampart" or "the Company"), a company committed to improving the lives of people suffering from pain by developing a...